FDA Recall Terminated Historical recordClass II
Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.
- Reason
- Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
- Published
- September 25, 2019
- Distribution
- Nationwide
